Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
Abstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four si...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3255 |
id |
doaj-459aa443dbf64da88da60748573933db |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniel DiCenzo Karina Quiaoit Kashuf Fatima Divya Bhardwaj Lakshmanan Sannachi Mehrdad Gangeh Ali Sadeghi‐Naini Archya Dasgupta Michael C. Kolios Maureen Trudeau Sonal Gandhi Andrea Eisen Frances Wright Nicole Look Hong Arjun Sahgal Greg Stanisz Christine Brezden Robert Dinniwell William T. Tran Wei Yang Belinda Curpen Gregory J. Czarnota |
spellingShingle |
Daniel DiCenzo Karina Quiaoit Kashuf Fatima Divya Bhardwaj Lakshmanan Sannachi Mehrdad Gangeh Ali Sadeghi‐Naini Archya Dasgupta Michael C. Kolios Maureen Trudeau Sonal Gandhi Andrea Eisen Frances Wright Nicole Look Hong Arjun Sahgal Greg Stanisz Christine Brezden Robert Dinniwell William T. Tran Wei Yang Belinda Curpen Gregory J. Czarnota Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study Cancer Medicine imaging biomarker locally advanced breast cancer machine learning neoadjuvant chemotherapy quantitative ultrasound radiomics |
author_facet |
Daniel DiCenzo Karina Quiaoit Kashuf Fatima Divya Bhardwaj Lakshmanan Sannachi Mehrdad Gangeh Ali Sadeghi‐Naini Archya Dasgupta Michael C. Kolios Maureen Trudeau Sonal Gandhi Andrea Eisen Frances Wright Nicole Look Hong Arjun Sahgal Greg Stanisz Christine Brezden Robert Dinniwell William T. Tran Wei Yang Belinda Curpen Gregory J. Czarnota |
author_sort |
Daniel DiCenzo |
title |
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study |
title_short |
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study |
title_full |
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study |
title_fullStr |
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study |
title_full_unstemmed |
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study |
title_sort |
quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: results from multi‐institutional study |
publisher |
Wiley |
series |
Cancer Medicine |
issn |
2045-7634 |
publishDate |
2020-08-01 |
description |
Abstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four sites across North America, and appropriate approval was obtained from the individual ethics committees. Eighty‐two patients with LABC were included for final analysis. Primary tumors were scanned using a clinical ultrasound system before NAC was started. The tumors were contoured, and radiofrequency data were acquired and processed from whole tumor regions of interest. QUS spectral parameters were derived from the normalized power spectrum, and texture analysis was performed based on six QUS features using a gray level co‐occurrence matrix. Patients were divided into responder or nonresponder classes based on their clinical‐pathological response. Classification analysis was performed using machine learning algorithms, which were trained to optimize classification accuracy. Cross‐validation was performed using a leave‐one‐out cross‐validation method. Results Based on the clinical outcomes of NAC treatment, there were 48 responders and 34 nonresponders. A K‐nearest neighbors (K‐NN) approach resulted in the best classifier performance, with a sensitivity of 91%, a specificity of 83%, and an accuracy of 87%. Conclusion QUS‐based radiomics can predict response to NAC based on pretreatment features with acceptable accuracy. |
topic |
imaging biomarker locally advanced breast cancer machine learning neoadjuvant chemotherapy quantitative ultrasound radiomics |
url |
https://doi.org/10.1002/cam4.3255 |
work_keys_str_mv |
AT danieldicenzo quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT karinaquiaoit quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT kashuffatima quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT divyabhardwaj quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT lakshmanansannachi quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT mehrdadgangeh quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT alisadeghinaini quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT archyadasgupta quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT michaelckolios quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT maureentrudeau quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT sonalgandhi quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT andreaeisen quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT franceswright quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT nicolelookhong quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT arjunsahgal quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT gregstanisz quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT christinebrezden quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT robertdinniwell quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT williamttran quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT weiyang quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT belindacurpen quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy AT gregoryjczarnota quantitativeultrasoundradiomicsinpredictingresponsetoneoadjuvantchemotherapyinpatientswithlocallyadvancedbreastcancerresultsfrommultiinstitutionalstudy |
_version_ |
1724630992763748352 |
spelling |
doaj-459aa443dbf64da88da60748573933db2020-11-25T03:17:37ZengWileyCancer Medicine2045-76342020-08-019165798580610.1002/cam4.3255Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional studyDaniel DiCenzo0Karina Quiaoit1Kashuf Fatima2Divya Bhardwaj3Lakshmanan Sannachi4Mehrdad Gangeh5Ali Sadeghi‐Naini6Archya Dasgupta7Michael C. Kolios8Maureen Trudeau9Sonal Gandhi10Andrea Eisen11Frances Wright12Nicole Look Hong13Arjun Sahgal14Greg Stanisz15Christine Brezden16Robert Dinniwell17William T. Tran18Wei Yang19Belinda Curpen20Gregory J. Czarnota21Department of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Physics Ryerson University Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaMedical Oncology Department of Medicine Sunnybrook Health Sciences Centre Toronto ON CanadaSurgical Oncology Department of Surgery Sunnybrook Health Sciences Centre Toronto ON CanadaSurgical Oncology Department of Surgery Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaPhysical Sciences Sunnybrook Research Institute Toronto ON CanadaMedical Oncology Saint Michael's HospitalUniversity of Toronto Toronto ON CanadaDepartment of Radiation Oncology Princess Margaret HospitalUniversity Health Network Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Diagnostic Radiology University of Texas Houston TX USADepartment of Medical Imaging Sunnybrook Health Sciences Centre Toronto ON CanadaDepartment of Radiation Oncology Sunnybrook Health Sciences Centre Toronto ON CanadaAbstract Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This was a multicenter study involving four sites across North America, and appropriate approval was obtained from the individual ethics committees. Eighty‐two patients with LABC were included for final analysis. Primary tumors were scanned using a clinical ultrasound system before NAC was started. The tumors were contoured, and radiofrequency data were acquired and processed from whole tumor regions of interest. QUS spectral parameters were derived from the normalized power spectrum, and texture analysis was performed based on six QUS features using a gray level co‐occurrence matrix. Patients were divided into responder or nonresponder classes based on their clinical‐pathological response. Classification analysis was performed using machine learning algorithms, which were trained to optimize classification accuracy. Cross‐validation was performed using a leave‐one‐out cross‐validation method. Results Based on the clinical outcomes of NAC treatment, there were 48 responders and 34 nonresponders. A K‐nearest neighbors (K‐NN) approach resulted in the best classifier performance, with a sensitivity of 91%, a specificity of 83%, and an accuracy of 87%. Conclusion QUS‐based radiomics can predict response to NAC based on pretreatment features with acceptable accuracy.https://doi.org/10.1002/cam4.3255imaging biomarkerlocally advanced breast cancermachine learningneoadjuvant chemotherapyquantitative ultrasoundradiomics |